Strock CJ - Search Results

1

Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells.

Strock CJ, Park JI, Nakakura EK, Bova GS, Isaacs JT, Ball DW, Nelkin BD. Strock CJ, et al. Cancer Res. 2006 Aug 1;66(15):7509-15. doi: 10.1158/0008-5472.CAN-05-3048. Cancer Res. 2006. PMID: 16885348

2

CEP-701 and CEP-751 inhibit constitutively activated RET tyrosine kinase activity and block medullary thyroid carcinoma cell growth.

Strock CJ, Park JI, Rosen M, Dionne C, Ruggeri B, Jones-Bolin S, Denmeade SR, Ball DW, Nelkin BD. Strock CJ, et al. Cancer Res. 2003 Sep 1;63(17):5559-63. Cancer Res. 2003. PMID: 14500395

3

Activity of irinotecan and the tyrosine kinase inhibitor CEP-751 in medullary thyroid cancer.

Strock CJ, Park JI, Rosen DM, Ruggeri B, Denmeade SR, Ball DW, Nelkin BD. Strock CJ, et al. J Clin Endocrinol Metab. 2006 Jan;91(1):79-84. doi: 10.1210/jc.2005-1882. Epub 2005 Nov 1. J Clin Endocrinol Metab. 2006. PMID: 16263812

4

Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling.

Feldmann G, Mishra A, Hong SM, Bisht S, Strock CJ, Ball DW, Goggins M, Maitra A, Nelkin BD. Feldmann G, et al. Among authors: strock cj. Cancer Res. 2010 Jun 1;70(11):4460-9. doi: 10.1158/0008-5472.CAN-09-1107. Epub 2010 May 18. Cancer Res. 2010. PMID: 20484029 Free PMC article.

5

The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway.

Park JI, Strock CJ, Ball DW, Nelkin BD. Park JI, et al. Among authors: strock cj. Mol Cell Biol. 2003 Jan;23(2):543-54. doi: 10.1128/MCB.23.2.543-554.2003. Mol Cell Biol. 2003. PMID: 12509453 Free PMC article.

6

GDNF-induced leukemia inhibitory factor can mediate differentiation via the MEK/ERK pathway in pheochromocytoma cells derived from nf1-heterozygous knockout mice.

Park JI, Powers JF, Tischler AS, Strock CJ, Ball DW, Nelkin BD. Park JI, et al. Among authors: strock cj. Exp Cell Res. 2005 Feb 1;303(1):79-88. doi: 10.1016/j.yexcr.2004.09.028. Exp Cell Res. 2005. PMID: 15572029

7

Interleukin-1beta can mediate growth arrest and differentiation via the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells.

Park JI, Strock CJ, Ball DW, Nelkin BD. Park JI, et al. Among authors: strock cj. Cytokine. 2005 Feb 7;29(3):125-34. doi: 10.1016/j.cyto.2004.10.005. Epub 2004 Dec 1. Cytokine. 2005. PMID: 15613280

8

Characterization of allosteric modulators that disrupt androgen receptor co-activator protein-protein interactions to alter transactivation-Drug leads for metastatic castration resistant prostate cancer.

Fancher AT, Hua Y, Close DA, Xu W, McDermott LA, Strock CJ, Santiago U, Camacho CJ, Johnston PA. Fancher AT, et al. Among authors: strock cj. SLAS Discov. 2023 Oct;28(7):325-343. doi: 10.1016/j.slasd.2023.08.001. Epub 2023 Aug 6. SLAS Discov. 2023. PMID: 37549772 Free article.

9

Assays to Interrogate the Ability of Compounds to Inhibit the AF-2 or AF-1 Transactivation Domains of the Androgen Receptor.

Fancher AT, Hua Y, Strock CJ, Johnston PA. Fancher AT, et al. Among authors: strock cj. Assay Drug Dev Technol. 2019 Nov/Dec;17(8):364-386. doi: 10.1089/adt.2019.940. Epub 2019 Sep 6. Assay Drug Dev Technol. 2019. PMID: 31502857 Free PMC article.

10

Screening for Neurotoxicity with Microelectrode Array.

Bradley JA, Strock CJ. Bradley JA, et al. Among authors: strock cj. Curr Protoc Toxicol. 2019 Feb;79(1):e67. doi: 10.1002/cptx.67. Epub 2018 Dec 21. Curr Protoc Toxicol. 2019. PMID: 30575314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page